里格尔制药 RIGL
$39.65 −$6.06 (-13.26%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $39.65 0.00%
开盘$41.11
昨收$45.71
当日区间$37.60 – $41.67
成交量759.2K
市值$746.61M
市盈率（TTM）2.5
股息率–
RIGL 相关新闻
匹配 Rigel Pharmaceuticals 或代码 RIGL 的头条新闻，按最新排序。
- Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $83 正面
- Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $83
- H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57
- Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $43 正面
- Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $49 正面
- H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $85 正面
- Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Cuts Target Price to $69 负面
- Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $81
- Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $81 正面
- Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Maintains Target Price $40
- Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Cuts Target Price to $40 负面
- Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $71
- Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Maintains Target Price $38
- Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $42 正面
- H.C. Wainwright Sticks to Their Buy Rating for Rigel (RIGL)
暂无评论——快来第一个聊聊 RIGL。
登录后参与讨论。